Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Limacher

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosineF Husseini, J-P Delord, C Fournel-Federico, et al.
Journal of the American College of Cardiology|July 21, 1998
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trialS J Lewis, F M Sacks, J S Mitchell, et al.
Annals of Internal Medicine|December 5, 1998
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trialS J Lewis, L A Moye, F M Sacks, et al.
Human Mutation|September 8, 1999
E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancerP J Guilford, J B Hopkins, W M Grady, et al.
Digestive Diseases and Sciences|October 31, 2022
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsM Baz, V Gondran-Teiller, B Bressac, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosineF Husseini, J-P Delord, C Fournel-Federico, et al.
Journal of the American College of Cardiology|July 21, 1998
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trialS J Lewis, F M Sacks, J S Mitchell, et al.
Annals of Internal Medicine|December 5, 1998
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trialS J Lewis, L A Moye, F M Sacks, et al.
Human Mutation|September 8, 1999
E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancerP J Guilford, J B Hopkins, W M Grady, et al.
Digestive Diseases and Sciences|October 31, 2022
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsM Baz, V Gondran-Teiller, B Bressac, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Pageof 4